StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMNov 12, 2026, 08:46 AM

NovaBay Pharmaceuticals Holds 2026 Annual Meeting; Directors Elected, Auditor Ratified

AI Summary

NovaBay Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders on November 10, 2026, with a quorum of 91.4% of outstanding shares present. Stockholders elected all three Class I director nominees for a three-year term and ratified the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Final voting results were certified by the inspector of election.

Key Highlights

  • NovaBay Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders on November 10, 2026.
  • A quorum was present with 91.4% of outstanding shares represented.
  • All three Class I director nominees, Michael Kazley, Yenyou (Jeff) Zheng, and Russell Preston Cann, were elected.
  • The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for fiscal year 2026 was ratified.
  • 47,156,315 votes were cast in favor of ratifying the accounting firm.